277 related articles for article (PubMed ID: 34793290)
1. A novel panel of blood-based microRNAs capable of discrimination between benign breast disease and breast cancer at early stages.
Sadeghi H; Kamal A; Ahmadi M; Najafi H; Sharifi Zarchi A; Haddad P; Shayestehpour B; Kamkar L; Salamati M; Geranpayeh L; Lashkari M; Totonchi M
RNA Biol; 2021 Nov; 18(sup2):747-756. PubMed ID: 34793290
[TBL] [Abstract][Full Text] [Related]
2. Serum microRNA as potential biomarker to detect breast atypical hyperplasia and early-stage breast cancer.
An X; Quan H; Lv J; Meng L; Wang C; Yu Z; Han J
Future Oncol; 2018 Dec; 14(30):3145-3161. PubMed ID: 30220214
[TBL] [Abstract][Full Text] [Related]
3. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
[TBL] [Abstract][Full Text] [Related]
4. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
[TBL] [Abstract][Full Text] [Related]
5. A Signature of Four Circulating microRNAs as Potential Biomarkers for Diagnosing Early-Stage Breast Cancer.
Itani MM; Nassar FJ; Tfayli AH; Talhouk RS; Chamandi GK; Itani ARS; Makoukji J; Boustany RN; Hou L; Zgheib NK; Nasr RR
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34204158
[TBL] [Abstract][Full Text] [Related]
6. A Competing Endogenous RNA Network Reveals Novel lncRNA, miRNA and mRNA Biomarkers With Diagnostic and Prognostic Value for Early Breast Cancer.
Luo ZB; Lai GE; Jiang T; Cao CL; Peng T; Liu FE
Technol Cancer Res Treat; 2020; 19():1533033820983293. PubMed ID: 33371806
[TBL] [Abstract][Full Text] [Related]
7. Underexpression of circulating miR-145-5p and miR-133a-3p are associated with breast cancer and immunohistochemical markers.
García-Magallanes N; Beltran-Ontiveros SA; Leal-León EA; Luque-Ortega F; Romero-Quintana JG; Osuna-Ramirez I; Barbosa-Jasso M; Arámbula-Meraz E
J Cancer Res Ther; 2020; 16(6):1223-1228. PubMed ID: 33342777
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of circulating MiR-30b-5p identifies advanced breast cancer.
Estevão-Pereira H; Lobo J; Salta S; Amorim M; Lopes P; Cantante M; Reis B; Antunes L; Castro F; Palma de Sousa S; Gonçalves CS; Costa BM; Henrique R; Jerónimo C
J Transl Med; 2019 Dec; 17(1):435. PubMed ID: 31888645
[TBL] [Abstract][Full Text] [Related]
9. Identification of a six-microRNA signature as a potential diagnostic biomarker in breast cancer tissues.
Mahmoudian M; Razmara E; Mahmud Hussen B; Simiyari M; Lotfizadeh N; Motaghed H; Khazraei Monfared A; Montazeri M; Babashah S
J Clin Lab Anal; 2021 Nov; 35(11):e24010. PubMed ID: 34528314
[TBL] [Abstract][Full Text] [Related]
10. Potential value of circulatory microRNA10b gene expression and its target E-cadherin as a prognostic and metastatic prediction marker for breast cancer.
Dwedar FI; Shams-Eldin RS; Nayer Mohamed S; Mohammed AF; Gomaa SH
J Clin Lab Anal; 2021 Aug; 35(8):e23887. PubMed ID: 34264524
[TBL] [Abstract][Full Text] [Related]
11. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
12. microRNA expression profiling on individual breast cancer patients identifies novel panel of circulating microRNA for early detection.
Hamam R; Ali AM; Alsaleh KA; Kassem M; Alfayez M; Aldahmash A; Alajez NM
Sci Rep; 2016 May; 6():25997. PubMed ID: 27180809
[TBL] [Abstract][Full Text] [Related]
13. Combined detection of plasma miR-127-3p and HE4 improves the diagnostic efficacy of breast cancer.
Lu M; Ju S; Shen X; Wang X; Jing R; Yang C; Chu H; Cong H
Cancer Biomark; 2017; 18(2):143-148. PubMed ID: 27983524
[TBL] [Abstract][Full Text] [Related]
14. A five-miRNA panel in plasma was identified for breast cancer diagnosis.
Li M; Zou X; Xia T; Wang T; Liu P; Zhou X; Wang S; Zhu W
Cancer Med; 2019 Nov; 8(16):7006-7017. PubMed ID: 31568692
[TBL] [Abstract][Full Text] [Related]
15. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
Kodahl AR; Lyng MB; Binder H; Cold S; Gravgaard K; Knoop AS; Ditzel HJ
Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of color Doppler ultrasound combined with plasma miR-21 and miR-27a in the diagnosis of breast cancer.
Li M; Li Q; Yin Q; Wang Y; Shang JM; Wang LH
Clin Transl Oncol; 2021 Apr; 23(4):709-717. PubMed ID: 33206330
[TBL] [Abstract][Full Text] [Related]
17. A two-miRNA signature of upregulated miR-185-5p and miR-362-5p as a blood biomarker for breast cancer.
Zhang K; Wang YY; Xu Y; Zhang L; Zhu J; Si PC; Wang YW; Ma R
Pathol Res Pract; 2021 Jun; 222():153458. PubMed ID: 33962174
[TBL] [Abstract][Full Text] [Related]
18. Five serum-based miRNAs were identified as potential diagnostic biomarkers in gastric cardia adenocarcinoma.
Wang J; Zhang H; Zhou X; Wang T; Zhang J; Zhu W; Zhu H; Cheng W
Cancer Biomark; 2018; 23(2):193-203. PubMed ID: 30198863
[TBL] [Abstract][Full Text] [Related]
19. Plasma microRNA ratios associated with breast cancer detection in a nested case-control study from a mammography screening cohort.
Chiorino G; Petracci E; Sehovic E; Gregnanin I; Camussi E; Mello-Grand M; Ostano P; Riggi E; Vergini V; Russo A; Berrino E; Ortale A; Garena F; Venesio T; Gallo F; Favettini E; Frigerio A; Matullo G; Segnan N; Giordano L
Sci Rep; 2023 Jul; 13(1):12040. PubMed ID: 37491482
[TBL] [Abstract][Full Text] [Related]
20. Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast Cancer.
Garrido-Cano I; Constâncio V; Adam-Artigues A; Lameirinhas A; Simón S; Ortega B; Martínez MT; Hernando C; Bermejo B; Lluch A; Lopes P; Henrique R; Jerónimo C; Cejalvo JM; Eroles P
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33050096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
